Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.31B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$339M |
| 3 |
Tesla
TSLA
|
+$275M |
| 4 |
Alibaba
BABA
|
+$236M |
| 5 |
AGN
Allergan plc
AGN
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$474M |
| 2 |
Gilead Sciences
GILD
|
+$359M |
| 3 |
Amazon
AMZN
|
+$274M |
| 4 |
Intel
INTC
|
+$248M |
| 5 |
Microsoft
MSFT
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.94% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.42% |
| 4 | Communication Services | 1.04% |
| 5 | Healthcare | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
CALL
iShares US Home Construction ETF
ITB
$2.25B
| $2.76M | ﹤0.01% |
75,600
-90,300
| -54% | -$3.11M |
|
3327
Sabra Healthcare REIT
SBRA
$5.27B
| $2.76M | ﹤0.01% |
+125,868
| New | +$2.84M |
|
|
BAS
3328
PUT
DELISTED
Basis Energy Services, Inc.
BAS
| $2.76M | ﹤0.01% |
143,100
-4,600
| -3% | -$91.2K |
|
3329
PTC Therapeutics
PTCT
$5.85B
| $2.76M | ﹤0.01% |
137,970
+75,240
| +120% | +$1.47M |
|
|
NLSN
3330
DELISTED
Nielsen Holdings plc
NLSN
| $2.76M | ﹤0.01% |
+66,600
| New | +$2.66M |
|
3331
American Eagle Outfitters
AEO
$2.83B
| $2.76M | ﹤0.01% |
193,021
-361,312
| -65% | -$4.42M |
|
|
SXCP
3332
PUT
DELISTED
SunCoke Energy Partners, L.P.
SXCP
| $2.76M | ﹤0.01% |
160,400
-8,500
| -5% | -$149K |
|
|
TVRD
3333
CALL
Tvardi Therapeutics
TVRD
$24.3M
| $2.75M | ﹤0.01% |
5,586
-3,861
| -41% | -$1.93M |
|
|
AERI
3334
DELISTED
Aerie Pharmaceuticals
AERI
| $2.75M | ﹤0.01% |
56,600
+44,121
| +354% | +$2.41M |
|
3335
Travelers Companies
TRV
$77.2B
| $2.75M | ﹤0.01% |
22,442
-10,758
| -32% | -$1.34M |
|
|
MINI
3336
PUT
DELISTED
Mobile Mini Inc
MINI
| $2.75M | ﹤0.01% |
+79,700
| New | +$2.45M |
|
3337
Xerox
XRX
$402M
| $2.75M | ﹤0.01% |
82,454
-75,209
| -48% | -$2.37M |
|
|
AIMT
3338
CALL
DELISTED
Aimmune Therapeutics
AIMT
| $2.74M | ﹤0.01% |
110,600
+99,700
| +915% | +$2.15M |
|
|
WRK
3339
PUT
DELISTED
WestRock Company
WRK
| $2.74M | ﹤0.01% |
48,300
+35,000
| +263% | +$2M |
|
3340
PUT
Vanguard High Dividend Yield ETF
VYM
$82.8B
| $2.73M | ﹤0.01% |
33,700
-7,900
| -19% | -$627K |
|
3341
CALL
Expeditors International
EXPD
$24.8B
| $2.73M | ﹤0.01% |
45,600
+27,600
| +153% | +$1.58M |
|
3342
CALL
iShares MSCI Canada ETF
EWC
$6.85B
| $2.73M | ﹤0.01% |
94,300
-59,700
| -39% | -$1.66M |
|
|
SOHU
3343
PUT
Sohu.com
SOHU
$368M
| $2.73M | ﹤0.01% |
50,100
-27,100
| -35% | -$1.42M |
|
3344
PUT
EPR Properties
EPR
$4.56B
| $2.73M | ﹤0.01% |
39,100
+15,500
| +66% | +$1.09M |
|
3345
CALL
Gray Television
GTN
$497M
| $2.73M | ﹤0.01% |
173,700
+47,800
| +38% | +$683K |
|
3346
Vale
VALE
$64B
| $2.72M | ﹤0.01% |
+270,536
| New | +$2.72M |
|
3347
iShares MSCI Austria ETF
EWO
$209M
| $2.72M | ﹤0.01% |
116,226
-52,013
| -31% | -$1.18M |
|
|
LBRDA
3348
PUT
DELISTED
Liberty Broadband Class A
LBRDA
| $2.72M | ﹤0.01% |
28,900
+20,900
| +261% | +$1.99M |
|
|
CBPO
3349
PUT
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $2.72M | ﹤0.01% |
29,500
+16,200
| +122% | +$1.56M |
|
3350
PUT
ProShares UltraPro Russell2000
URTY
$325M
| $2.72M | ﹤0.01% |
35,700
+12,100
| +51% | +$791K |
|
Similar funds
Jeff Yass's Q3 2017 Portfolio in Review
As of Q3 2017, Jeff Yass held 10,422 positions worth $259B, up 14% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q3 2017 filing shows 1,312 new, 3,605 increased, 3,645 reduced and 1,693 closed positions. Its largest new stake was JPMorgan Chase: 794,224 shares worth $75.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $474M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2017 buy was JPMorgan Chase: 794,224 shares worth $75.9M.
- Jeff Yass added most to Apple in Q3 2017, an estimated $1.31B increase.
- Jeff Yass's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $474M.
- Jeff Yass fully exited iShares 20+ Year Treasury Bond ETF in Q3 2017, selling an estimated $69.3M.
- Jeff Yass's ten largest holdings make up 24% of its $259B portfolio in Q3 2017.
- Jeff Yass opened 1,312 new positions and closed 1,693 in Q3 2017.
- Jeff Yass's portfolio value rose 14% quarter-over-quarter to $259B.
Based on Susquehanna International Group's 13F filing for Q3 2017, filed 14 Nov 2017.